Massey Sally
Known title: Chief People OfficerCIK: 0001815662
Associated companies
Transaction History
| CL | ▲ Buy | Grant | 3,333 | $0 | 9/16/2026 | View on chart |
| CL | ▼ Sell | Tax Withholding | 686 | $60K | 9/13/2026 | View on chart |
| CL | ▼ Sell | Tax Withholding | 459 | $40K | 9/12/2026 | View on chart |
| CL | ▼ Sell | Tax Withholding | 651 | $57K | 9/11/2026 | View on chart |
| CL | ▼ Sell | Open Market | 8,599 | $752K | 5/7/2026 | View on chart |
| CL | ▲ Buy | Grant | 16,805 | $0 | 2/23/2026 | View on chart |
| CL | ▼ Sell | Tax Withholding | 8,206 | $797K | 2/23/2026 | View on chart |
| CL | ▲ Buy | Option Exercise | 15,851 | $1.2M | 2/5/2026 | View on chart |
| CL | ▼ Sell | Open Market | 15,851 | $1.5M | 2/5/2026 | View on chart |
| CL | ▼ Sell | Open Market | 1,237 | $100K | 11/21/2025 | View on chart |
| CL | ▼ Sell | Tax Withholding | 669 | $56K | 9/13/2025 | View on chart |
| CL | ▼ Sell | Tax Withholding | 447 | $37K | 9/12/2025 | View on chart |
| CL | ▲ Buy | Grant | 3,450 | $0 | 9/11/2025 | View on chart |
| CL | ▼ Sell | Open Market | 2,250 | $200K | 5/15/2025 | View on chart |
| CL | ▼ Sell | Open Market | 8,000 | $736K | 2/25/2025 | View on chart |
| CL | ▲ Buy | Grant | 12,132 | $0 | 2/13/2025 | View on chart |
| CL | ▼ Sell | Tax Withholding | 5,057 | $444K | 2/13/2025 | View on chart |
| CL | ▼ Sell | Tax Withholding | 652 | $69K | 9/13/2024 | View on chart |
| CL | ▲ Buy | Grant | 2,370 | $0 | 9/12/2024 | View on chart |
| CL | ▲ Buy | Option Exercise | 15,850 | $1.2M | 8/6/2024 | View on chart |
| CL | ▼ Sell | Open Market | 15,850 | $1.6M | 8/6/2024 | View on chart |
| CL | ▲ Buy | Option Exercise | 12,226 | $884K | 5/9/2024 | View on chart |
| CL | ▼ Sell | Open Market | 12,226 | $1.1M | 5/9/2024 | View on chart |
| CL | ▲ Buy | Option Exercise | 6,115 | $442K | 5/1/2024 | View on chart |
| CL | ▼ Sell | Open Market | 6,115 | $562K | 5/1/2024 | View on chart |
| CL | ▼ Sell | Tax Withholding | 1,489 | $124K | 2/18/2024 | View on chart |
| CL | ▼ Sell | Tax Withholding | 2,262 | $189K | 2/15/2024 | View on chart |
| CL | ▲ Buy | Grant | 5,468 | $0 | 2/15/2024 | View on chart |
| CL | ▲ Buy | Grant | 3,461 | $0 | 9/13/2023 | View on chart |
| CL | ▲ Buy | Option Exercise | 14,594 | $1.1M | 5/15/2023 | View on chart |
| CL | ▼ Sell | Open Market | 14,594 | $1.2M | 5/15/2023 | View on chart |
| CL | ▲ Buy | Option Exercise | 17,239 | $1.2M | 5/4/2023 | View on chart |
| CL | ▼ Sell | Open Market | 17,239 | $1.4M | 5/4/2023 | View on chart |
| CL | ▼ Sell | Open Market | 1,009 | $74K | 2/17/2023 | View on chart |
| CL | ▲ Buy | Grant | 1,666 | $0 | 2/16/2023 | View on chart |
| CL | ▼ Sell | Open Market | 656 | $51K | 9/13/2022 | View on chart |
| CL | ▼ Sell | Open Market | 1,624 | $129K | 2/18/2022 | View on chart |
| CL | ▲ Buy | Grant | 2,764 | $0 | 2/17/2022 | View on chart |
| CL | ▼ Sell | Open Market | 610 | $47K | 9/14/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
Colgate-Palmolive dividend focus ahead of Q3 earnings call
Recent coverage lists Colgate‑Palmolive as a dividend champion and a contender for income‑focused investors. The company will host its 2026 third‑quarter earnings webcast on October 30, where results and guidance are expected. Investors noting the upcoming November 13 dividend should be aware of the October 20 record date to qualify for the payment. The stock continues to trade with a dividend yield of about 2.5%.
Colgate-Palmolive dividend focus ahead of Q3 earnings call. Recent coverage lists Colgate‑Palmolive as a dividend champion and a contender for income‑focused investors. The company will host its 2026 third‑quarter earnings webcast on October 30, where results and guidance are expected. Investors noting the upcoming November 13 dividend should be aware of the October 20 record date to qualify for the payment. The stock continues to trade with a dividend yield of about 2.5%.